Matthew Freedman, M.D.

Matthew Freedman, M.D., is Professor of Medicine at Harvard Medical School and Chair of Dana-Farber Cancer Institute in Boston, where he specializes in medical oncology with a clinical focus on prostate cancer treatment. His research encompasses cancer genomics, diagnostic innovations, and the intersection of cancer biology with metabolic and lipid pathways, work that directly informs personalized treatment approaches for patients. Dr. Freedman's contributions to the field are reflected in over